Genmark Diagnostics announces public offering

GenMark Diagnostics (GNMK) announces a $60M public offering.

All of the shares in the proposed offering are to be sold by GNMK.

JPMorgan is acting as sole book-runner. Shares -5% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs